Sucampo Pharma (SCMP) Tops Q2 EPS by 6c; Boosts FY15 EPS Outlook
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Research and development revenue: 3.17M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development revenue: 3.17M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Sucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.21, $0.06 better than the analyst estimate of $0.15. Revenue for the quarter came in at $34.9 million versus the consensus estimate of $31.9 million.
Sucampo Pharma sees FY2015 EPS of $0.65-$0.75, versus the consensus of $0.62.
For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
